Berlin, Germany

Andrea Hägebarth

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

**Title: Andrea Hägebarth: Innovator in Pharmaceutical Patents**

Introduction

Andrea Hägebarth is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, Hägebarth has made notable advancements, particularly in the treatment of diseases such as cancer through innovative chemical compounds and combinations.

Latest Patents

Among his latest patented inventions, Hägebarth has developed compounds that relate to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides. These compounds are designed to be useful in preparing pharmaceutical compositions for the treatment and prevention of diseases, including cancer. The general formula and details of these compounds reflect their complexity and potential impact on cancer treatment.

In addition, Hägebarth has patented a combination of PI3K inhibitors, comprising two components: one being an inhibitor of the PI3K kinase and the other a pharmaceutically acceptable salt of radium 223. This combination aims to enhance treatment options for patients with cancer that has metastasized to the bones.

Career Highlights

Throughout his career, Hägebarth has worked with reputable organizations, notably at Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His tenure at these companies has been marked by a focus on innovation and the development of new therapeutic agents.

Collaborations

Hägebarth's work has also led to fruitful collaborations with noteworthy professionals, including Ulf Bömer and William Johnston Scott. These partnerships have fostered the development and refinement of his innovative ideas, further contributing to his success in the pharmaceutical industry.

Conclusion

In conclusion, Andrea Hägebarth exemplifies the spirit of innovation in the pharmaceutical sector. His extensive portfolio of patents demonstrates his commitment to advancing medical science, especially in cancer treatment. As a leading inventor, Hägebarth continues to influence the future of pharmaceuticals with his pioneering work and collaborative efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…